Therapeutic studies in hepatic encephalopathy

Metabolic Brain Disease

Volumn 22, Issue 3-4, 2007, Pages 407-423

  Mullen, Kevin D ^a   Amodio, Piero ^b   Morgan, Marsha Y ^c  

^a METROHEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Clinical trials; Hepatic encephalopathy; Measurement; Placebo treatment; Treatment study design

Indexed keywords

FLUMAZENIL; LACTITOL; LACTULOSE; PLACEBO;

BEHAVIORAL RESEARCH; CLINICAL STUDY; CONFERENCE PAPER; CORPUS CALLOSUM; CRITICAL FLICKER FUSION; DISEASE SEVERITY; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; EYE TRACKING; HEPATIC ENCEPHALOPATHY; HUMAN; MOTOR DYSFUNCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PSYCHOMETRY; RISK ASSESSMENT; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE;

CLINICAL TRIALS AS TOPIC; ELECTROENCEPHALOGRAPHY; FLICKER FUSION; HEPATIC ENCEPHALOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MOTOR ACTIVITY; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; RESEARCH DESIGN;

EID: 35449001682     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-007-9061-6     Document Type: Conference Paper

References (63)

1. Als-Nielsen B, Gluud LL, Gluud C (2004) Non-absorable disaccharides for hepatic encecephalopathy. A systemic review. Br Med J 328:1040-1050
2. Amodio P, Marchetti P, Del Piccolo F, Campo G, Rizzo C, Iemmolo RM, Gerundi G, Caregaro L, Merkel C, Gatta A (1998) Visual attention in cirrhotic patients: a study on covert visual attention orienting. Hepatology 27:1517-1523
3. Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A (1999a) Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 29:1662-1667
4. Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, Zuliani C, Campo G, Gatta A, Guerit JM (1999b) Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 110:1334-1344
5. Amodio P, Del Piccolo F, Petteno E, Mapelli D, Angeli P, Iemmolo R, Muraca M, Musto C, Gerunda G, Rizzo C, Merkel C, Gatta A (2001) Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 35:37-45
6. Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19:253-267
7. Barbaro G, DiLorenzo G, Sodini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G (1978) Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: An Italian, multicenter, double-blind, placebo-controlled cross-over study. Hepatology 28:374-378
8. Bergasa NV (2004) Treatment of the pruritis of cholestasis. Curr Treat Options Gastroenterol 7:501-508
9. Blanc P, Daures JP, Liautard J, Buttigieg R, Desprez D, Pageaux G, Allaz JL, Parelon G, Larrey D, Michel H (1994) Association lactulose-neomycine versus placebo dans le traitement de l'encephalopathie hepatique aigue. Resultats d'un essai controle randomise. Gastroenterol Clin Biol 18:1063-1068
10. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodés J (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890-895
11. Conn HO, Lieberthal MM (1978) The hepatic coma syndromes and lactulose. Williams & Williams, Baltimore
12. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 72:573-583
13. Córdoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L, Vargas V, Margarit C, Kulisewsky J, Esteban R, Guardia J (2001) The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 35:598-604
14. Dawson AM, McLaren J, Sherlock S (1957) Neomycin in the treatment of hepatic coma. Lancet 273: 1263-1268
15. Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB (2000) Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci 45:1549-1552
16. Douglass A, Al Mardini H, Record C (2001) Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy. J Hepatol 34:658-564
17. Ferenci P, Grimm G, Meryn S, Gamble A (1999) Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroenterology 96:240-243
18. Gentile S, Guarino G, Romano M, Alagia IA, Fierro M, Annunziata S, Magliano PL, Gravina AG, Torella R (2005) A randomized controlled trial of acarbose in hepatic encephalopathy. Clin Gastroenterol Hepatol 3:184-191
19. Grover VPB, Dresner MA, Forton DM, Counsell S, Larkman DJ, Patel N, Thomas HC, Taylor-Robinson SD (2006) Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol 12:2969-2978
20. Häussinger D (2006) Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 43:1187-90
21. Häussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J (1994) Proton magnetic resonance spectroscopy on human brain myo-inositol in hypo-osmolality and hepatic encephalopathy. Gastroenterology 107:1475-1480
22. Hely MA, Chey T, Wilson A, Williamson PM, O'Sullivan DJ, Rail D, Morris JG (1993) Reliability of the Columbia scale for assessing signs of Parkinson's disease. Mov Disord 8:466-472
23. Iversen P, Hansen DA, Bender D, Rodell A, Munk OL, Cumming P, Keiding S (2006) Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy. Eur J Nucl Med Mol Imaging 33:810-816
24. Iwasa M, Kinosada Y, Nakatsuka A, Watanabe S, Adachi Y (1999) Magnetization transfer contrast of various regions of the brain in liver cirrhosis. AJNR Am J Neuroradiol 20:652-654
25. Joebges EM, Heideman M, Schimke N, Hecke H, Ennen JC, Weissenborn K (2003) Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation. J Hepatol 38:273-280
26. Jover R, Company L, Gutierrez A, Zapater P, Perez-Serra J, Girona E, Aparicio JR, Perez-Mateo M (2003) Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. Am J Gastroenterol 98:1599-1604
27. Kale RA, Gupta RK, Saraswat VA, Hasan KM, Trivedi R, Mishra AM, Rajan P, Pandey CM, Narayana PA (2006) Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 43:698-706
28. 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 43:42-50
29. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ Rink C, Rösch W, Stauch S (1997) Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 25:1351-1360
30. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35:357-366
31. Krieger S, Jauss M, Jansen O, Theilmann L, Geissler M, Krieger D (1996) Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis [see comments]. Gastroenterology 111:147-155
32. Kulisevsky J, Conill J, Avila A, Pujol J, Balanzo J, Capdevila A (1995) Abnormalities of the Bereitschaftspotential and MRI pallidal signal in non-encephalopathic cirrhotic patients. Electroencephalogr Clin Neurophysiol 94:425-431
33. Lockwood AH, Murphy BW, Donnelly KZ, Mahl TC, Perini S (1993) Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 18:1061-1068
34. Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W (2002) Correlations between cerebral glucose metabolism and neuropsychological test performance in non-alcoholic cirrhotics. Metab Brain Dis 17:29-40
35. Mas A, Rodés J, Sunyer L, Rodrigo L, Planas R, Vargas V, Castells L, Rodriguez-Martinez D, Fernández-Rodriguez C, Coll I, Pardo A, Spanish Association for the Study of the Liver Hepatic Encephalopathy Cooperative Group (2003) Comparison of rifaximin and lactitol in the treatment of acute hepatic encepyhalopathy: Results of a randomized, double-blind, double-dummy controlled clinical trial. J Hepatol 8:51-58
36. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR. Am J Neuroradiol 27:1019-1026
37. Montagnese S, Jackson C, Gordon HM, Jethwa N, Sherratt RM, Morgan MY (2005) Smooth pursuit eye movements: does chronic liver disease affect the eye tracking of smooth trajectories. Hepatology 42:772-781
38. Montagnese S, Jackson C, Morgan MY (2007) Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. J Hepatol 46:447-458
39. Mullen KD, Howard R (2005) Is acarbose an effective drug for treating patients with cirrhosis and hepatic encephalopathy? Nat Clin Pract Gastroenterol Hepatol 2:264-265
40. Natsch S, Kullberg BJ, Hekster YA, van der Meer JW (2003) Selecting outcome parameters in studies aimed at improving rational use of antibiotics-practical considerations. J Clin Pharm Ther 28:475-478
41. Ortiz M, Córdoba J, Jacas C, Flavià M, Esteban R, Guardia J (2006) Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 44:104-110
42. Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock S (1957) The electroencephalograph in liver disease. Lancet II:867-871
43. Patel N, White S, Dhanjal NS, Oatridge A, Taylor-Robinson SD (2004) Changes in brain size in hepatic encephalopathy: a coregistered MRI study. Metab Brain Dis 19:431-445
44. Pellegrini A, Ubiali E, Orsato R, Schiff S, Gatta A, Castellaro A, Casagrande A, Amodio P (2005) Electroencephalographic staging of hepatic encephalopathy by an artificial neural network and an expert system. Clin Neurophysiol 35:162-167
45. Riggio O, Masini A, Efrati C, Nicolao F, Angeloni S, Salvatori FM, Bezzi M, Attili AF, Merli M (2005) Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol 42:674-679
46. Romero-Gomez M, Córdoba J, Jover R, Del-Olmo JA, Ramírez M, Flavià M, Comapñy N, Rodrigo JM, Felipo V (2006) Usefulness of the measurement of critical flicker frequency in the diagnosis of minimal hepatic encephalopathy [Abstract]. J Hepatol 44(Suppl 2):S93-S230
47. Rovira A, Grive E, Pedraza S, Rovira A, Alonso J (2001) Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR. Am J Neuroradiol 22:1137-1142
48. Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK (2002) Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 22:190-197
49. Schiff S, Vallesi A, Mapelli D, Orsato R, Pellegrini A, Umiltà C, Gatta A, Amodio P (2005) Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study. Metab Brain Dis 20:381-392
50. Schomerus H, Hamster W (1998) Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13:361-377
51. Sharma P, Sharma BC, Sarin SK, Puri V (2006) Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy [Abstract]. J Hepatol 44(Suppl 2):S93-S94, 232
52. Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E (2006) Diabetes Mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol 101:1490-1496
53. Strauss E, da Costa MF (1998) The importance of bacterial infections as precipitating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology 45:900-904
54. Strauss E, Tramote R, Silva EP, Caly WR, Honain NZ, Maffei RA, de Sá MF (1992) Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatology 39:542-545
55. Timmermann L, Gross J, Butz M, Kircheis G, Häussinger D, Schnitzler A (2003) Mini-asterixis in hepatic encephalopathy induced by pathologic thalmo-motor-cortical coupling. Neurology 61:689-692
56. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N (2001) Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 13:229-242
57. Wein C, Koch H, Popp B, Oehler G, Schauder P (2004) Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 39:739-745
58. Weissenborn K, Scholz M, Hinrichs H, Wiltfang J, Schmidt FW, Künkel H (1990) Neuropsychological assessment of early hepatic encephalopathy. Electroencephalogr Clin Neurophysiol 75:289-295
59. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001a) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768-773
60. Weissenborn K, Heidenreich S, Ennen J, Rückert N, Hecker H (2001b) Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 16:13-19
61. Weissenborn K, Heidenreich S, Giewekemeyer K, Rückert N, Hecker H (2003) Memory function in early hepatic encephalopathy. J Hepatol 39:320-325
62. Weissenborn K, Giewekemeyer K, Heidenreich S, Bokemeyer M, Berding G, Ahl B (2005) Attention, memory, and cognitive function in hepatic encephalopathy. Metab Brain Dis 20:359-367
63. Zafiris O, Kircheis G, Rood HA, Boers F, Häussinger D, Zilles K (2004) Neural mechanism underlying impaired visual judgment in the dysmetabolic brain: fMRI study. NeuroImage 22:541-552